THE
3002.15.00

Tariff line in 3002.15 — Antisera and other blood fractions and modified immunological products, whether or not obtained by m…

Antisera and other blood fractions and modified immunological products, whether or not obtained by m…

Immunological products, put up in measured doses or in forms or packings for retail sale

$397MIndia’s exports in FY 2025-26
138countries bought from India
+30%against FY 2024-25 ($306M)
521tonnes shipped in FY 2025-26

India’s exports, year by year

US$, Indian financial years (April–March). Source: DGCI&S, Ministry of Commerce (Tradestat).

Biggest buyers, FY 2025-26

  1. United States
  2. Netherlands
  3. United Kingdom
  4. Vietnam
  5. Algeria
  6. Russia
  7. Canada
  8. Colombia
  9. Australia
  10. Brazil

Ranked by value. Country-by-country figures are not shown.

GST on this code

0% or 5%

  • 5% — Animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures whether or not modifiedNotification 9/2025-CT(R), Schedule I, entry 231
  • 5% — Animal or Human Blood VaccinesNotification 9/2025-CT(R), Schedule I, entry 232
  • 0% — Human Blood and its componentsNotification 10/2025-CT(R), entry 114

GST on supply within India, as of 1 May 2026. Exports are zero-rated supplies.